Mankind Pharma Limited (MANKIND) — Corporate Action

📢 Key Event
Allotment of 86,778 ESOP shares increases paid-up capital to 41,29,95,978 shares.

🔄 What Changed
Paid-up share capital rose from 41,29,09,200 to 41,29,95,978 shares.

💡 Investor Takeaway
Shareholders will see diluted holdings due to the new ESOP issuance.

Mankind Pharma announced the allotment of 86,778 equity shares under its ESOP 2022 plan on June 8, 2026, increasing the paid-up share capital from 41,29,09,200 to 41,29,95,978 shares, each with a face value of ₹1, as disclosed in the filing.

📄 View Original Announcement (PDF)

📊 Stock Analysis — MANKIND ✨ Ask AI About This

About Mankind Pharma Limited (MANKIND)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,03,330.93 Cr P/E: 49.2

View full MANKIND stock details →

📡 Get AI alerts when MANKIND files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MANKIND — Free

💡 Ask AI about this filing

"How does this affect MANKIND margins?" "Compare with last quarter results" "What should investors watch for?"

Ask AI Free →

📊 More MANKIND filings

See all MANKIND filings →

🔥 Also filed on 8 June 2026

RBLBANK RBL Bank Limited Insider Trading LEMONTREE Lemon Tree Hotels Limited Announcement SEDEMAC SEDEMAC Mechatronics Limited Announcement SURAJEST Suraj Estate Developers Limited Insider Trading STEELCAS Steelcast Limited Financial Results FINOPB Fino Payments Bank Limited Insider Trading

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when MANKIND files new disclosures

Track MANKIND filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track MANKIND — Free

Free account · 2 AI queries/day